Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance

NCT04071613 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT04071613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
Lead sponsor
Melbourne Health
Phase
Phase 2
Overall status
Completed
Start date
June 20, 2019
Completion date
November 16, 2021
Enrollment
104 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute, stroke ischemic